Basic info
Industry
biotechnology research
Sectors
Biotechnology
cancer
cell dormancy
TET2
Biopharma
cancer persistence
precision oncology
Therapeutics
Spin-off
first-in-class
biopharmaceutical
Targeted therapy
Date founded
2021
Funding rounds raised
Total raised
$1.4M
from 1 investors over 1 rounds
O
Oniria Therapeutics raised $1.4M on May 11, 2023
Investors: Fundación Botín